source
- FDA proposes 50% fee cut for US early-stage trials, but industry says speed matters moreThe FDA announced a proposal to cut the application fee by half for drugs that run their early-stage trials in the United States. The reduction, about $2.3 million at current rates, is intended to…
- August biopharma layoffs impact just over 500, down 90% year over yearLast month, biotech and pharma companies making or planning workforce cuts included three whose reductions will more than halve their workforces. Blueprint Medicines’ layoffs will affect the most e…BioSpace · 37m ago↗ source